These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


528 related items for PubMed ID: 32721816

  • 1. Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.
    Wang Q, Xu G, Xia Y, Zuo J, Zeng G, Xue Z, Cao R, Xiong W, Li W.
    Oral Oncol; 2020 Dec; 111():104925. PubMed ID: 32721816
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Zhou R, Zhu J, Chen X, Liu Y, Wang Y, Zhang T.
    Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sequential induction chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: the three-year report of a phase II, single center, randomized, non-inferiority trial.
    Yang Z, Cai Z, Cai Q, Hong Y, Zhang C, Huang K, Lin Z, Li M.
    Cancer Med; 2021 Jun; 10(12):3886-3895. PubMed ID: 33955190
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysis.
    Wang BC, Xiao BY, Lin GH, Wang C, Liu Q.
    BMC Cancer; 2020 May 06; 20(1):393. PubMed ID: 32375701
    [Abstract] [Full Text] [Related]

  • 6. Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study.
    Liu L, Fei Z, Chen M, Zhao L, Su H, Gu D, Lin B, Cai X, Lu L, Gao M, Ye X, Jin X, Xie C.
    Radiat Oncol; 2018 Aug 13; 13(1):148. PubMed ID: 30103765
    [Abstract] [Full Text] [Related]

  • 7. Induction chemotherapy for locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiation: A systematic review and meta-analysis.
    Tan TH, Soon YY, Cheo T, Ho F, Wong LC, Tey J, Tham IWK.
    Radiother Oncol; 2018 Oct 13; 129(1):10-17. PubMed ID: 29555182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Survival benefit of induction chemotherapy in treatment for stage III or IV locally advanced nasopharyngeal carcinoma - An updated meta-analysis and systematic review.
    Hu T, Fang L, Shi L, Wang W, Huang Y.
    Am J Otolaryngol; 2021 Oct 13; 42(5):102973. PubMed ID: 33812206
    [Abstract] [Full Text] [Related]

  • 10. Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter study.
    Zhang B, Hu Y, Xiong RH, Pan YF, Xu QL, Kong XY, Cai R, Chen QQ, Tang HY, Jiang W.
    Oncotarget; 2017 Feb 21; 8(8):14078-14088. PubMed ID: 27845907
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A network meta-analysis for efficacies and toxicities of different therapeutic regimens in the treatment of advanced nasopharyngeal carcinoma.
    Li T, Yang F, Ma K, Lv L.
    Eur Arch Otorhinolaryngol; 2021 Sep 21; 278(9):3333-3344. PubMed ID: 33517538
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.